Recurrent miscarriage: current concepts in diagnosis and treatment.

PubWeight™: 1.28‹?› | Rank: Top 10%

🔗 View Article (PMID 20185181)

Published in J Reprod Immunol on February 24, 2010

Authors

Bettina Toth1, Udo Jeschke, Nina Rogenhofer, Christoph Scholz, Wolfgang Würfel, Christian J Thaler, Antonis Makrigiannakis

Author Affiliations

1: Department of Gynecological Endocrinology and Fertility Disorders, Ruprecht-Karl University Heidelberg, Vossstr 9, 69115 Heidelberg, Germany. bettina.toth@med.uni-heidelberg.de

Articles citing this

Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid (2011) 8.77

Association of IL-17A and IL-17 F gene polymorphisms with recurrent pregnancy loss in Iranian women. J Assist Reprod Genet (2014) 0.87

Positive association of Apolipoprotein E4 polymorphism with recurrent pregnancy loss in Iranian patients. J Assist Reprod Genet (2013) 0.85

StuI polymorphism on the androgen receptor gene is associated with recurrent spontaneous abortion. J Assist Reprod Genet (2013) 0.85

Identification of key contributory factors responsible for vascular dysfunction in idiopathic recurrent spontaneous miscarriage. PLoS One (2013) 0.84

Granulocyte colony-stimulating factor (G-CSF): a mediator in endometrial receptivity for a patient with polycystic ovary (PCO) undergoing in vitro maturation (IVM). BMJ Case Rep (2013) 0.81

First Trimester Pregnancy Loss and the Expression of Alternatively Spliced NKp30 Isoforms in Maternal Blood and Placental Tissue. Front Immunol (2015) 0.79

Apolipoprotein E (Apo E) gene polymorphisms and recurrent pregnancy loss: a meta-analysis. J Assist Reprod Genet (2013) 0.78

Association of TNF-α genetic polymorphisms with recurrent pregnancy loss risk: a systematic review and meta-analysis. Reprod Biol Endocrinol (2016) 0.78

Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG (S1-Level, AWMF Registry No. 015/050, December 2013). Geburtshilfe Frauenheilkd (2015) 0.78

A high dose intravenous immunoglobulin therapy for women with four or more recurrent spontaneous abortions. ISRN Obstet Gynecol (2012) 0.78

Association between HLA-E gene polymorphism and unexplained recurrent spontaneous abortion (RSA) in Iranian women. Int J Reprod Biomed (Yazd) (2016) 0.77

Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review. Clin Rev Allergy Immunol (2017) 0.77

Defects in the vasoactive intestinal peptide (VIP)/VPAC system during early stages of the placental-maternal leucocyte interaction impair the maternal tolerogenic response. Clin Exp Immunol (2012) 0.76

Placental Microparticles and MicroRNAs in Pregnant Women with Plasmodium falciparum or HIV Infection. PLoS One (2016) 0.75

Genetic variation in leptin and leptin receptor genes is a risk factor for idiopathic recurrent spontaneous abortion. Croat Med J (2016) 0.75

Combination of aspirin and heparin in unexplained recurrent miscarriages - "Empirical or evidence based". J Hum Reprod Sci (2011) 0.75

Effectiveness of aspirin compare with heparin plus aspirin in recurrent pregnancy loss treatment: A Quasi experimental study. Iran J Reprod Med (2014) 0.75

Reduced expressions of connexin 43 and VEGF in the first-trimester tissues from women with recurrent pregnancy loss. Reprod Biol Endocrinol (2016) 0.75

Treatment of recurrent pregnancy loss by Levothyroxine in women with high Anti-TPO antibody. Iran J Reprod Med (2012) 0.75

Articles by these authors

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med (2003) 16.62

Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme. Ann Intern Med (2015) 4.60

Hormonal contraception--what kind, when, and for whom? Dtsch Arztebl Int (2011) 2.47

The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERbeta, and enhances expression of oncogenic cytokine GRO. Cancer Biol Ther (2008) 1.73

Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women. Thromb Haemost (2007) 1.57

Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril (2008) 1.53

Evaluation of a novel anti-mucin 1 (MUC1) antibody (PankoMab) as a potential diagnostic tool in human ductal breast cancer; comparison with two established antibodies. Onkologie (2009) 1.51

Ontogenetic regulation of leukocyte recruitment in mouse yolk sac vessels. Blood (2013) 1.45

Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration. Am J Physiol Cell Physiol (2002) 1.43

Endothelial function, but not carotid intima-media thickness, is affected early in menopause and is associated with severity of hot flushes. J Clin Endocrinol Metab (2010) 1.32

Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis (2013) 1.28

Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified? Breast Cancer Res Treat (2010) 1.15

Syncytiotrophoblast is a barrier to maternal-fetal transmission of herpes simplex virus. Biol Reprod (2002) 1.14

Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone. Anticancer Res (2005) 1.13

FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs. J Assist Reprod Genet (2006) 1.10

Prognostic significance of estrogen receptor alpha and beta expression in human serous carcinomas of the ovary. Arch Gynecol Obstet (2009) 1.08

Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells. Cancer Res (2002) 1.08

Prognostic significance of oestrogen receptor alpha (ERalpha) and beta (ERbeta), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas. Eur J Cancer (2007) 1.06

Circulating microparticles in breast cancer patients: a comparative analysis with established biomarkers. Anticancer Res (2008) 1.04

Role of immunoreceptor tyrosine-based inhibitory motifs of PECAM-1 in PECAM-1-dependent cell migration. Am J Physiol Cell Physiol (2004) 1.04

Factors controlling blastocyst implantation. Reprod Biomed Online (2005) 1.03

Subtle progesterone rise on the day of human chorionic gonadotropin administration is associated with lower live birth rates in women undergoing assisted reproductive technology: a retrospective study with 2,555 fresh embryo transfers. Fertil Steril (2012) 1.02

High pregnancy rates with administration of granulocyte colony-stimulating factor in ART-patients with repetitive implantation failure and lacking killer-cell immunglobulin-like receptors. Hum Reprod (2010) 1.01

Expression of E-cadherin and its repressor snail in placental tissue of normal, preeclamptic and HELLP pregnancies. Virchows Arch (2007) 0.99

Gender-specific and menstrual cycle dependent differences in circulating microparticles. Platelets (2007) 0.98

Expression pattern of the activating protein-1 family of transcription factors in the human placenta. Mol Hum Reprod (2004) 0.98

The association between vitamin D receptor expression and prolonged overall survival in breast cancer. J Histochem Cytochem (2011) 0.97

Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy. Arthritis Rheum (2010) 0.96

Opposed roles of follicle-stimulating hormone and luteinizing hormone receptors in ovarian cancer survival. Histopathology (2011) 0.96

Predictors of endothelial dysfunction in young women with polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 0.95

The role of stress in female reproduction and pregnancy: an update. Ann N Y Acad Sci (2010) 0.95

Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival. BMC Cancer (2012) 0.94

Human umbilical vascular endothelial cells express estrogen receptor beta (ERbeta) and progesterone receptor A (PR-A), but not ERalpha and PR-B. Histochem Cell Biol (2008) 0.94

Governing the invasive trophoblast: current aspects on intra- and extracellular regulation. Am J Reprod Immunol (2010) 0.94

Fibrinolytic defects and recurrent miscarriage: a systematic review and meta-analysis. Obstet Gynecol (2007) 0.93

Placental interleukin-15 expression in recurrent miscarriage. Am J Reprod Immunol (2010) 0.92

Glycodelin A induces a tolerogenic phenotype in monocyte-derived dendritic cells in vitro. Am J Reprod Immunol (2008) 0.92

Expression of endothelial NO synthase, inducible NO synthase, and estrogen receptors alpha and beta in placental tissue of normal, preeclamptic, and intrauterine growth-restricted pregnancies. J Histochem Cytochem (2005) 0.91

Endometrial pinopodes and uterine receptivity. Ann N Y Acad Sci (2003) 0.91

Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients. Breast Cancer Res Treat (2006) 0.91

Effectivity of heparin in assisted reproduction. Eur J Med Res (2004) 0.90

Plasma- and urine concentrations of nitrite/nitrate and cyclic Guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies. Arch Gynecol Obstet (2006) 0.90

Peroxisome proliferator-activated receptors: new players in the field of reproduction. Am J Reprod Immunol (2007) 0.90

Offspring after embryo-preserving biopsy of the embryoblast with standard ICSI equipment in mouse blastocysts. In Vivo (2011) 0.89

Immunohistochemical analysis of estrogen receptor alpha, estrogen receptor beta and progesterone receptor in normal human endometrium. Acta Histochem (2004) 0.89

In breast cancer, a high ratio of tumour-infiltrating intraepithelial CD8+ to FoxP3+ cells is characteristic for the medullary subtype. Histopathology (2011) 0.88

Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer. BMC Cancer (2012) 0.88

Best practices of ASRM and ESHRE: a journey through reproductive medicine. Fertil Steril (2012) 0.87

Relationship between recurrent vulvovaginal candidosis and immune mediators in vaginal fluid. Eur J Obstet Gynecol Reprod Biol (2009) 0.87

Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis. Oncol Rep (2005) 0.87

Glycodelin A is expressed differentially in normal human endometrial tissue throughout the menstrual cycle as assessed by immunohistochemistry and in situ hybridization. Fertil Steril (2006) 0.87

Granulocyte-colony stimulating factor as treatment option in patients with recurrent miscarriage. Arch Immunol Ther Exp (Warsz) (2013) 0.87

Galectin-1 induced activation of the apoptotic death-receptor pathway in human Jurkat T lymphocytes. Histochem Cell Biol (2008) 0.87

Novel trends in follicular development, atresia and corpus luteum regression: a role for apoptosis. Reprod Biomed Online (2005) 0.87

Disorders of implantation--are there diagnostic and therapeutic options? J Reprod Immunol (2011) 0.87

Expression pattern of the CCAAT/enhancer-binding proteins C/EBP-alpha, C/EBP-beta and C/EBP-delta in the human placenta. Virchows Arch (2003) 0.86

Inherited thrombophilia: impact on human reproduction. Am J Reprod Immunol (2003) 0.86

Diagnostic biomarkers of pro-inflammatory immune-mediated preterm birth. Arch Gynecol Obstet (2012) 0.86

High levels of p110δ PI3K expression in solid tumor cells suppress PTEN activity, generating cellular sensitivity to p110δ inhibitors through PTEN activation. FASEB J (2012) 0.86

Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy. Antivir Ther (2009) 0.86

Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen. Clin Exp Metastasis (2008) 0.86

Sperm retrieval procedures and intracytoplasmatic spermatozoa injection with epididymal and testicular sperms. Urol Int (2003) 0.86

Activation of melanoma differentiation-associated gene 5 causes rapid involution of the thymus. J Immunol (2009) 0.86

Effect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: a prospective randomized study. Fertil Steril (2010) 0.86

Premature ovarian failure, endothelial dysfunction and estrogen-progestogen replacement. Trends Endocrinol Metab (2006) 0.86

P53 expression in vulvar carcinoma, vulvar intraepithelial neoplasia, squamous cell hyperplasia and lichen sclerosus. Anticancer Res (2005) 0.85

Predictive value of early serum beta-hCG levels after single blastocyst transfer. Acta Obstet Gynecol Scand (2009) 0.85

Comparison of circulating tumor cells (CTC) in peripheral blood and disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients. J Cancer Res Clin Oncol (2013) 0.85

Decidual macrophages are significantly increased in spontaneous miscarriages and over-express FasL: a potential role for macrophages in trophoblast apoptosis. Int J Mol Sci (2012) 0.84

Immunohistochemical labelling of steroid receptors in normal and malignant human endometrium. Acta Histochem (2009) 0.84

Osteopontin is colocalized with the adhesion molecule CEACAM1 in the extravillous trophoblast of the human placenta and enhances invasion of CEACAM1-expressing placental cells. J Clin Endocrinol Metab (2005) 0.84

The Role of PPARs in Placental Immunology: A Systematic Review of the Literature. PPAR Res (2013) 0.84

Estrogen receptor modulators and estrogen receptor beta immunolabelling in human umbilical vein endothelial cells. Acta Histochem (2008) 0.83

Nuclear receptors of the peroxisome proliferator-activated receptor (PPAR) family in gestational diabetes: from animal models to clinical trials. Biol Reprod (2010) 0.83

Systemic changes in haemostatic balance are not associated with increased levels of circulating microparticles in women with recurrent spontaneous abortion. Am J Reprod Immunol (2008) 0.83

Knocking off the suppressors of cytokine signaling (SOCS): their roles in mammalian pregnancy. J Reprod Immunol (2009) 0.83

Recent advances in understanding immunology of reproductive failure. J Reprod Immunol (2011) 0.83

The G-protein-coupled estrogen receptor (GPER) is expressed in normal human ovaries and is upregulated in ovarian endometriosis and pelvic inflammatory disease involving the ovary. Reprod Sci (2012) 0.83

Menopausal status in breast cancer patients with past chemotherapy determines long-term hypoactive sexual desire disorder. J Sex Med (2011) 0.83

Synchronous expression of pinopodes and alpha v beta 3 and alpha 4 beta 1 integrins in the endometrial surface epithelium of normally menstruating women during the implantation window. J Reprod Med (2003) 0.83

Involvement of galectin-1 in reproduction: past, present and future. Hum Reprod Update (2013) 0.83

Survival analysis between patients with invasive ductal and invasive lobular breast cancer. Arch Gynecol Obstet (2008) 0.83

Vasoconstrictively acting AT1R A1166C and NOS3 4/5 polymorphisms in recurrent spontaneous abortions (RSA). Am J Reprod Immunol (2004) 0.83

Is galectin-1 a trigger for trophoblast cell fusion?: the MAP-kinase pathway and syncytium formation in trophoblast tumour cells BeWo. Mol Hum Reprod (2011) 0.83

Corticotropin-releasing hormone modulates human trophoblast invasion through carcinoembryonic antigen-related cell adhesion molecule-1 regulation. Am J Pathol (2006) 0.83

Peroxisome proliferator-activated receptor-gamma (PPARγ) is down regulated in trophoblast cells of gestational diabetes mellitus (GDM) and in trophoblast tumour cells BeWo in vitro after stimulation with PPARγ agonists. J Perinat Med (2014) 0.83

Thyroid hormone receptor (TR)alpha and TRbeta expression in breast cancer. Histol Histopathol (2013) 0.83

Lack of prognostic relevance of Her-2/neu, topoisomerase IIα and EGFR in advanced ovarian carcinoma. Exp Ther Med (2012) 0.82

Immunohistochemistry, glycosylation and immunosuppression of glycodelin in human ovarian cancer. Histochem Cell Biol (2008) 0.82